Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02410 TYK MEDICINES-B
RT Nominaldown24.350 -0.400 (-1.616%)
Disclosure of Interest
More
20/08/2024 16:08
{New Stock}TYK MEDICINES-B(02410) ends up 13.22% at HK$13.7
[ET Net News Agency, 20 August 2024] Shares of TYK MEDICINES-B (02410) closed at HK$13.7 in its first trading day, or 13.2% higher than its offer p ... View All View All

20/08/2024 09:20    {New Stock}TYK MEDICINES-B opens up 19.67% at HK$14.48

19/08/2024 18:35    {New Stock}TYK MEDICINES-B ends up 9.09% on grey market

19/08/2024 16:20    {New Stock}TYK MEDICINES-B up 7.44% at HK$13 on grey market

Remark: Real time quote last updated: 19/11/2024 11:56
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.